Skip to content
Sale

Perry W. Buffington – Psychopharmacology 2-Day Conference

Original price was: $439.99.Current price is: $74.70.

[Instant Download] – Immediately deliver the download link after receiving the payment

Description

Unlock your potential with the Unlock your potential with the Perry W. Buffington - Psychopharmacology 2-Day ConferencePerry W. Buffington - Psychopharmacology 2-Day Conference course for only course for only Original price was: $439.99.Original price was: $439.99.Current price is: $74.70.Current price is: $74.70. at at Giolib.comGiolib.com! Explore our comprehensive library of over 60,000 downloadable digital courses across various ! Explore our comprehensive library of over 60,000 downloadable digital courses across various Medical & HealthMedical & Health. Get expert-led, self-paced learning at up to 80% savings. Elevate your skills today!. Get expert-led, self-paced learning at up to 80% savings. Elevate your skills today!

Faculty:Faculty:
Perry W. BuffingtonPerry W. Buffington
Duration:Duration:
12 Hours 12 Minutes12 Hours 12 Minutes
Format:Format:
Audio and VideoAudio and Video
Copyright:Copyright:
Sep 14, 2017Sep 14, 2017

Description

Handouts

Outline

DAY ONEDAY ONE

PSYCHOPHARMACOLOGYPSYCHOPHARMACOLOGY

  • Historical antecedents of modern psychopharmacologyHistorical antecedents of modern psychopharmacology
  • Diagnostic issuesDiagnostic issues
  • Clarification of termsClarification of terms
  • Drug metabolism concepts: pharmacokinetics & pharmacodynamicsDrug metabolism concepts: pharmacokinetics & pharmacodynamics
  • Drug mechanism of actionDrug mechanism of action
  • Placebo & NoceboPlacebo & Nocebo
  • Pharmacotherapy vs. PharmacotherapyPharmacotherapy vs. Pharmacotherapy
  • Developing highly effective collaborations with prescribersDeveloping highly effective collaborations with prescribers

DEPRESSIVE DISORDERSDEPRESSIVE DISORDERS

  • Biogenic Amine, Cortisol, Down-Regulation, & Neurotropic HypothesesBiogenic Amine, Cortisol, Down-Regulation, & Neurotropic Hypotheses
  • Neurochemistry of depressionNeurochemistry of depression
  • Types of anti-depressantsTypes of anti-depressants
  • Preventing side effectsPreventing side effects
  • Tardive Dysphoria: real or imagined?Tardive Dysphoria: real or imagined?

ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERSANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERS

  • Neurochemistry of anxietyNeurochemistry of anxiety
  • GAD, panic disorders, phobiasGAD, panic disorders, phobias
  • OCDOCD
  • PTSDPTSD
  • Physiological interventionsPhysiological interventions
  • Anti-anxiety medicationsAnti-anxiety medications
  • Anti-depressantsAnti-depressants
  • Non-pharmacologic optionsNon-pharmacologic options
  • Benzodiazepines: risks and benefitsBenzodiazepines: risks and benefits
  • Preventing side effectsPreventing side effects

BIPOLAR DISORDERSBIPOLAR DISORDERS

  • NeurochemistryNeurochemistry
  • The Bipolar Spectrum & DSM-5® ChangesThe Bipolar Spectrum & DSM-5® Changes
  • Mood stabilizers Mood stabilizers
    • LithiumLithium
    • Anti-convulsants & neuromodulatorsAnti-convulsants & neuromodulators
  • Typical, atypical, & third-generation antipsychoticsTypical, atypical, & third-generation antipsychotics
  • Effective strategies for improving outcomes for clientsEffective strategies for improving outcomes for clients

PSYCHOTIC DISORDERS/ SCHIZOPHRENIAPSYCHOTIC DISORDERS/ SCHIZOPHRENIA

  • Neurochemistry of psychosis and schizophreniaNeurochemistry of psychosis and schizophrenia
  • Antipsychotic Medications: Antipsychotic Medications:
    • First generation (typical)First generation (typical)
    • Second generation (atypical)Second generation (atypical)
  • Managing side effects Managing side effects
    • Extrapyramidal symptoms and TDExtrapyramidal symptoms and TD
    • Metabolic problems- what blood tests are needed and whenMetabolic problems- what blood tests are needed and when
    • Preventing Diabetes MellitusPreventing Diabetes Mellitus
  • Recognizing hyperprolactinemia- and why you need to knowRecognizing hyperprolactinemia- and why you need to know
  • Use of atypical antipsychotics for multiple disordersUse of atypical antipsychotics for multiple disorders

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKSLIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

DAY TWODAY TWO

ATTENTIONAL DISORDERSATTENTIONAL DISORDERS

  • Differential diagnosisDifferential diagnosis
  • Neurochemistry of ADHDNeurochemistry of ADHD
  • Treatment controversiesTreatment controversies
  • Substance abuse and ADHDSubstance abuse and ADHD
  • Stimulant medicationsStimulant medications
  • Non-stimulant optionsNon-stimulant options
  • Preventing side effectsPreventing side effects

SUBSTANCE ABUSE DISORDERSSUBSTANCE ABUSE DISORDERS

  • Neurochemistry of addictionNeurochemistry of addiction
  • Negative reinforcement & creation of habitsNegative reinforcement & creation of habits
  • AlcoholAlcohol
  • CaffeineCaffeine
  • NicotineNicotine
  • CannabisCannabis
  • OpiatesOpiates
  • PCP & KetaminePCP & Ketamine
  • MDMA (Ecstasy)MDMA (Ecstasy)
  • Energy vs. Chill DrinksEnergy vs. Chill Drinks
  • Over-the-counter & herbal psychopharmacologyOver-the-counter & herbal psychopharmacology
  • Addiction treatmentsAddiction treatments
  • Behavioral addictionsBehavioral addictions

SPECIAL POPULATIONSSPECIAL POPULATIONS

  • Specialized guidelines for geriatric patientsSpecialized guidelines for geriatric patients
  • Dementia treatmentDementia treatment
  • Slow vs. rapid metabolizers (genetic polymorphisms)Slow vs. rapid metabolizers (genetic polymorphisms)

TREATING CLIENTS PAINTREATING CLIENTS PAIN

  • Acute vs. chronic painAcute vs. chronic pain
  • Alternatives to pharmacologyAlternatives to pharmacology
  • Pain vs. depression: which comes first?Pain vs. depression: which comes first?

ETHICS & PSYCHOPHARMACOLOGYETHICS & PSYCHOPHARMACOLOGY

  • High-risk pharmacology & psychopharmacologyHigh-risk pharmacology & psychopharmacology
  • Off-label use of medicationsOff-label use of medications
  • Prescribing for childrenPrescribing for children
  • Elective psychopharmacologyElective psychopharmacology
  • Marketing of mental illnessMarketing of mental illness
  • PolypharmacyPolypharmacy
  • Informed vs. uninformed consentInformed vs. uninformed consent
  • Patient & third party pressuresPatient & third party pressures
  • Professional boundariesProfessional boundaries
  • Ethics associated with medical errorsEthics associated with medical errors
  • Role of placeboRole of placebo

FUTURE TRENDSFUTURE TRENDS

  • Change of mind: preventing vs. managing side effectsChange of mind: preventing vs. managing side effects
  • Medicalization of normalMedicalization of normal
  • Computer assisted devicesComputer assisted devices
  • New meds, new diagnoses, new theories, new normalNew meds, new diagnoses, new theories, new normal
  • Top 10 Medical EmergenciesTop 10 Medical Emergencies
  • Integrating psychotherapy with psychopharmacologyIntegrating psychotherapy with psychopharmacology

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKSLIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

Faculty

Perry W. Buffington, PH.D., MS Related seminars and products: 2


Perry Buffington, Ph.D., M.S.,Perry Buffington, Ph.D., M.S., has over 20 years of experience in the medical consulting field and is currently a full-time senior lecturer at the University of Georgia, teaching psychopharmacology at the undergraduate and graduate levels. He is former chairman of the prestigious Florida Psychological Association’s Prescriptive Authority Committee and teaches seminars nationwide on minimizing psychopharmacological errors. has over 20 years of experience in the medical consulting field and is currently a full-time senior lecturer at the University of Georgia, teaching psychopharmacology at the undergraduate and graduate levels. He is former chairman of the prestigious Florida Psychological Association’s Prescriptive Authority Committee and teaches seminars nationwide on minimizing psychopharmacological errors.

As the author of eight books (currently working on his first psychopharmacology text), his by-line has appeared in hundreds of periodicals including the As the author of eight books (currently working on his first psychopharmacology text), his by-line has appeared in hundreds of periodicals including the Saturday Evening Post, USA Today,Saturday Evening Post, USA Today, and and Success.Success. He is the former contributing editor for Delta Air Lines’ in-flight magazine, He is the former contributing editor for Delta Air Lines’ in-flight magazine, Sky,Sky, and served as a syndicated newspaper/web columnist for Universal Press. Additional, he hosted his own radio show, syndicated nationally, by Envison Radio Networks. and served as a syndicated newspaper/web columnist for Universal Press. Additional, he hosted his own radio show, syndicated nationally, by Envison Radio Networks.

Perry’s presentation style is engaging, a blend of education and entertainment; as a result, critics (and especially his students) applaud his ability to make complicated topics understandable and applicable – even useful!! Perry’s presentation style is engaging, a blend of education and entertainment; as a result, critics (and especially his students) applaud his ability to make complicated topics understandable and applicable – even useful!!

Speaker Disclosures:Speaker Disclosures:

Financial:Financial: Perry Buffington is the President of Go-Buff Enterprises, Inc. He is a member of the psychology faculty, Franklin College of Arts & Sciences, The University of Georgia. Dr. Buffington receives a speaking honorarium from PESI, Inc. Perry Buffington is the President of Go-Buff Enterprises, Inc. He is a member of the psychology faculty, Franklin College of Arts & Sciences, The University of Georgia. Dr. Buffington receives a speaking honorarium from PESI, Inc.

Nonfinancial:Nonfinancial: Perry Buffington has no relevant nonfinancial relationship to disclose. Perry Buffington has no relevant nonfinancial relationship to disclose.


Salepage: Salepage: https://catalog.pesi.com//item/psychopharmacology-2day-conference-24536
Archive: Archive: https://archive.ph/wip/TqeiF

Future-proof your knowledge with the Future-proof your knowledge with the Perry W. Buffington - Psychopharmacology 2-Day ConferencePerry W. Buffington - Psychopharmacology 2-Day Conference course at course at GiOlibGiOlib! Enjoy lifetime access to high-quality digital content, crafted to advance your career and personal development.! Enjoy lifetime access to high-quality digital content, crafted to advance your career and personal development.

  • Lifetime Access:Lifetime Access: Permanent access to all purchased courses. Permanent access to all purchased courses.
  • Smart Savings:Smart Savings: Benefit from prices up to 80% off original course costs. Benefit from prices up to 80% off original course costs.
  • Safe Transactions:Safe Transactions: Process your payments securely. Process your payments securely.
  • Practical Insights:Practical Insights: Gain actionable skills relevant to today's demands. Gain actionable skills relevant to today's demands.
  • Instant Availability:Instant Availability: Begin your course immediately after payment. Begin your course immediately after payment.
  • Flexible Learning:Flexible Learning: Access content effortlessly on any device. Access content effortlessly on any device.

Start expanding your horizons with Start expanding your horizons with GiOlibGiOlib!!

Cart
Back To Top